Cost-effectiveness analysis of a randomized trial of recovery management checkups for adults with chronic substance use disorders

s / Drug and Alcohol Dependence 140 (2014) e86–e168 e139 Financial support: Supported by NIDA research grants R01DA024678 and R01DA031160. http://dx.doi.org/10.1016/j.drugalcdep.2014.02.393 The medication research partnership Dennis McCarty1, R. Croff1, M. Chalk2, K. Alanis-Hirsch2, J. Kemp2, J. Ford3, K. Johnson3, L. Schmidt4 1 Oregon Health & Science University, Portland, OR, United States 2 Treatment Research Institute, Philadelphia, PA, United States 3 NIATx, Uuniversity of Wisconsin, Madison, WI, United States 4 UC San Francisco, San Francisco, CA, United States Aims: The Medication Research Partnership seeks to (a) accelerate medication-assisted treatment (MAT) for alcohol and opioid disorders, (b)monitorhealth careutilizationandcost, and (c) assess barriers and facilitators to enhance the use of medication to treat alcohol and drug use disorders. The partnership includes a commercial health plan and 9 addiction treatment centers contracting with the health plan. Methods: Thepartnershipuses a systemschangemodel emphasizinguseof financial, regulatory, operational, inter-organizational, and customer impact levers, to implement organizational and system change projects that increase access to and use of medication-assisted treatment. Results: Two treatment centers that streamlined intake processes reported a 52% increase in patients receiving medication and a 13% improvement in referrals from detox to outpatient. Two sites established criteria to assess patient appropriateness for MAT. Four sites developed medication treatment protocols. One site sought approval as an opioid treatment program. A second site increased patient adoption of extended-release naltrexone and are up to 2.5 injections per month. A third site increased the number and percent of patients prescribed extended-release naltrexone. The fourth site saw increased patient resistance to buprenorphine and increased interest in extended-release naltrexone. One site implemented physician training onMAT and increased the number of patients prescribed and receiving alcohol medications by 23%. The health plan provided case management assistance for patients using medication and encouraged treatment centers to prescribe medications. Conclusions:Organizational changeandsystemschange strategies can enhance the adoption of medication for treatment of alcohol and opioid dependence. Financial support: An award (R01 DA029716) from the National Institute on Drug Abuse supported the study. http://dx.doi.org/10.1016/j.drugalcdep.2014.02.394 Cost-effectiveness analysis of a randomized trial of recovery management checkups for adults with chronic substance use disorders K.E. McCollister1, M.T. French1,2, D.M. Freitas3, Michael L. Dennis4, C.K. Scott4, R.R. Funk4 1 University of Miami, Miami, FL, United States 2 University of Miami, Coral Gables, FL, United States 3 New York University, New York, NY, United States 4 Chestnut Health System, Normal & Chicago, IL,